Breast Cancer Research News
People with a history of breast cancer may want to consider COVID and flu vaccinations, according to the researchers.
The combination offered better outcomes than the THP chemo regimen.
After two years of follow-up, the new treatment improved survival and quality of life.
People lived longer without the cancer growing when they received Trodelvy and Keytruda compared to the current standard treatment.
The new medicine offered more benefits than Faslodex.
Adding the immunotherapy medicine camrelizumab to chemotherapy offered better outcomes than chemotherapy alone for TNBC.
The disparities may mean delays in diagnosis, which can lead to worse outcomes.
Research suggests current screening guidelines for brain mets need updating.
Abraxane instead of Taxotere and carboplatin led to a better response and fewer serious side effects.
Risks were higher for a new cancer in the opposite breast, as well as ovarian, pancreatic, and prostate cancers.
Some breast cancers may be more likely to come back as metastatic disease five to 10 years after surgery in people ages 35 and younger.
Two-year rates of invasive cancer were similar for women whether they had surgery or frequent mammograms, but more research is needed.
Combined with Verzenio, this new oral SERD may be a good option for advanced-stage breast cancer with an ESR1 mutation.
Progression-free survival was 15 months longer when Ibrance was added to standard treatment.
Treatments after surgery are more effective today and studies now include more women with lower-risk disease.
The longer women with the mutation used hormonal contraception, the bigger the increase in risk.
While the benefits of supplemental screening are clear, the additional screenings may also lead to more false alarms, which can take a financial and emotional toll on people.
Doing short bursts of intense exercise during chemo for early-stage breast cancer led to better outcomes.
Two international studies provide evidence on safety.
Enhertu is likely a valuable new treatment option for certain brain metastases.
Protection varied by race and decreased with age.
But there’s a tradeoff: People taking cannabis reported feeling more anxious and dizzy than people who didn’t take cannabis.
Just 90 minutes of moderate exercise a week seems to reduce the risk of hormone receptor-negative breast cancer coming back as metastatic disease in younger women.
The accuracy of AI programs to flag areas of concern on mammograms seems to depend on the diversity of the data used to create these programs.